USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2.

MDM2 RPS2 USP47 p53 ribosomal stress

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
01 May 2020
Historique:
received: 04 02 2020
revised: 23 04 2020
accepted: 24 04 2020
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 7 5 2020
Statut: epublish

Résumé

p53 is activated in response to cellular stresses such as DNA damage, oxidative stress, and especially ribosomal stress. Although the regulations of p53 by E3 ligase and deubiquitinating enzymes (DUBs) have been described, the cellular roles of DUB associated with ribosomal stress have not been well studied. In this study, we report that Ubiquitin Specific Protease 47 (USP47) functions as an important regulator of p53. We show that ubiquitinated ribosomal protein S2 (RPS2) by Mouse double minute 2 homolog (MDM2) is deubiquitinated by USP47. USP47 inhibits the interaction between RPS2 and MDM2 thereby alleviating RPS2-mediated suppression of MDM2 under normal conditions. However, dissociation of USP47 leads to RPS2 binding to MDM2, which is required for the suppression of MDM2, consequently inducing up-regulation of the p53 level under ribosomal stress. Finally, we show that depletion of USP47 induces p53 and therefore inhibits cell proliferation, colony formation, and tumor progression in cancer cell lines and a mouse xenograft model. These findings suggest that USP47 could be a potential therapeutic target for cancer.

Identifiants

pubmed: 32370049
pii: cancers12051137
doi: 10.3390/cancers12051137
pmc: PMC7281321
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Research Foundation of Korea
ID : 2017R1A2B3007224
Organisme : National Research Foundation of Korea
ID : 2019R1A2C2004052
Organisme : National Research Council of Science & Technology
ID : CAP-16-03-KRIBB

Références

EMBO Rep. 2018 Oct;19(10):
pubmed: 30206189
EMBO J. 2012 Feb 1;31(3):576-92
pubmed: 22124327
Biochem Biophys Res Commun. 2020 Mar 5;523(2):542-547
pubmed: 31928715
J Neurosci. 2013 Jul 31;33(31):12728-38
pubmed: 23904609
Mol Cell. 2008 Oct 24;32(2):180-9
pubmed: 18951086
Sci Rep. 2017 Nov 21;7(1):15918
pubmed: 29162839
Mol Cell. 2011 Mar 4;41(5):609-15
pubmed: 21362556
Cell Rep. 2013 Jul 11;4(1):87-98
pubmed: 23831031
Cell. 2009 May 15;137(4):609-22
pubmed: 19450511
BMB Rep. 2018 Nov;51(11):602-607
pubmed: 30269739
Cell. 2010 Feb 5;140(3):384-96
pubmed: 20096447
Antioxid Redox Signal. 2011 Sep 15;15(6):1669-78
pubmed: 21050134
Nat Med. 2011 Jul 31;17(8):944-51
pubmed: 21804542
Cell Rep. 2015 Jan 13;10(2):140-7
pubmed: 25578727
Mol Cancer Res. 2008 Jun;6(6):947-54
pubmed: 18567799
Nature. 2017 Oct 26;550(7677):481-486
pubmed: 29045389
Oncogene. 2012 Jun 21;31(25):3060-71
pubmed: 22081073
J Mol Cell Biol. 2015 Apr;7(2):92-104
pubmed: 25735597
Cell Death Dis. 2013 Oct 17;4:e867
pubmed: 24136231
EMBO Rep. 2017 Jan;18(1):123-137
pubmed: 27856536
Cell Chem Biol. 2017 Dec 21;24(12):1490-1500.e11
pubmed: 29056421
Nature. 2017 Oct 26;550(7677):534-538
pubmed: 29045385
Mol Cell. 2011 Dec 9;44(5):797-810
pubmed: 22152482
Cell Rep. 2013 Oct 17;5(1):237-47
pubmed: 24120868
Biochem Soc Trans. 2012 Jun 1;40(3):539-45
pubmed: 22616864
Cell. 2009 May 1;137(3):413-31
pubmed: 19410540
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20467-72
pubmed: 23169665
EMBO J. 2011 Jun 1;30(11):2177-89
pubmed: 21522127
Nat Commun. 2018 Feb 15;9(1):688
pubmed: 29449677
Mol Cell. 2012 May 25;46(4):484-94
pubmed: 22542455
Cells. 2012 Oct 15;1(4):774-98
pubmed: 24710530
EMBO J. 2007 Feb 21;26(4):976-86
pubmed: 17290220
Genes Dev. 2010 Jul 1;24(13):1434-47
pubmed: 20595234
Mol Cell. 2009 Aug 14;35(3):316-26
pubmed: 19683495
Mol Cell. 2006 Feb 3;21(3):307-15
pubmed: 16455486
BMB Rep. 2019 Mar;52(3):181-189
pubmed: 30760385
Elife. 2018 Mar 16;7:
pubmed: 29547122
Cancer Cell. 2010 Sep 14;18(3):231-43
pubmed: 20832751
ACS Med Chem Lett. 2012 Sep 11;3(10):789-92
pubmed: 24900381
Mol Cell. 2012 Mar 30;45(6):801-13
pubmed: 22361354
EMBO J. 2011 Nov 15;30(24):4921-30
pubmed: 22085928
Mol Cell Biol. 2000 May;20(9):3224-33
pubmed: 10757806
Nature. 2002 Apr 11;416(6881):648-53
pubmed: 11923872
Med Chem. 2018;14(1):3-18
pubmed: 29065837
J Biol Chem. 2011 Jul 1;286(26):22730-41
pubmed: 21561866
Oncogene. 2010 Mar 4;29(9):1384-93
pubmed: 19966869
Cell Physiol Biochem. 2017;43(5):1755-1766
pubmed: 29049989

Auteurs

Jinhong Cho (J)

Biomedical Research Institute, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Korea.
Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, 5-1 Anam-dong, Sungbuk-gu, Seoul 02841, Korea.

Jinyoung Park (J)

Molecular Recognition Research Center, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Korea.

Sang Chul Shin (SC)

Biomedical Research Institute, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Korea.

Mihue Jang (M)

Biomedical Research Institute, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Korea.

Jae-Hong Kim (JH)

Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, 5-1 Anam-dong, Sungbuk-gu, Seoul 02841, Korea.

Eunice EunKyeong Kim (EE)

Biomedical Research Institute, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Korea.

Eun Joo Song (EJ)

Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Korea.

Classifications MeSH